Dr. Oz hopes the program's data will reveal how many eligible beneficiaries choose to take the drugs.

Medicare is rolling out a new program that will provide low-cost access to GLP-1s for weight loss.

The Trump administration has officially launched its new "bridge" model that brings GLP-1 coverage for weight loss to Medicare beneficiaries. | The Trump administration has officially launched its new ...

The federal government has launched a new program to make GLP-1 weight loss drugs more affordable for older Americans.

The Medicare GLP-1 Bridge Program has opened and will remain open through 2027, giving some Medicare beneficiaries greater ...

Healthcare providers, pharmacies, telehealth companies, and healthcare organizations should prepare for the launch of CMS’s Medicare GLP-1 Bridge, ...

Medicare is launching a temporary program that will cover Novo’s Wegovy injection and tablets, as well as Lilly’s Zepbound ...

GLP-1 weight-loss drugs will cost $50 a month for many older adults starting July 1, as Medicare begins to cover them. How the Medicare GLP-1 Bridge plan works.

A financially sustainable solution for how to cover GLP-1 drugs for obesity remains elusive. The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 ...

Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology. Kelly ...

Some of the GLP-1 drugs approved by the FDA to reduce body weight, including Wegovy, will be soon be $50 a month for certain people enrolled in Medicare. (Michael Siluk/UCG/Universal Images Group via ...

Starting in July, some Medicare beneficiaries will be able to access GLP-1 medications by paying one flat fee per month. The temporary program is set to run for a year-and-a-half through the end of ...